Publications by authors named "Bram Goldstein"

Claim this Profile
A
A review of sunscreen in the prevention of skin cancer.
John P Micha, Randy D Bohart, Bram H Goldstein

J Oncol Pharm Pract· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy and Chemotherapy for Advanced or Recurrent Endometrial Carcinoma.
John P Micha, Randy D Bohart, Joshua P Gorman, Bram H Goldstein

Anticancer Res· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaping and Smoking Cessation.
John P Micha, Mark A Rettenmaier, Randy D Bohart, Bram H Goldstein

Subst Use Misuse· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical differences among the PARP inhibitors in the first-line treatment of advanced-stage ovarian carcinoma.
John P Micha, Mark A Rettenmaier, Randy Bohart, Joshua P Gorman, Bram H Goldstein

Expert Rev Anticancer Ther· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Statin use and ovarian cancer outcomes.
John P Micha, Mark A Rettenmaier, Randy D Bohart, Bram H Goldstein

Expert Rev Anticancer Ther· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medical marijuana in the treatment of cancer-associated symptoms.
John P Micha, Mark A Rettenmaier, Randy D Bohart, Bram H Goldstein

J Oncol Pharm Pract· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does Aspirin Use Reduce the Risk for Ovarian Cancer?
John P Micha, Mark A Rettenmaier, Randy D Bohart, Bram H Goldstein

Cancer Invest· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cyclin-dependent kinase 4/6 inhibitors in the treatment of advanced or metastatic breast cancer.
John P Micha, Mark A Rettenmaier, Randy D Bohart, Bram H Goldstein

J Oncol Pharm Pract· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to the letter to the editor: a response to Tran and Egilman.
John P Micha, Mark A Rettenmaier, Randy D Bohart, Bram H Goldstein

Arch Gynecol Obstet· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current analysis of the survival implications for minimally invasive surgery in the treatment of early-stage cervix cancer.
John P Micha, Mark A Rettenmaier, Randy D Bohart, Bram H Goldstein

J Robot Surg· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prolonged endocrine therapy in the management of hormone receptor-positive early-stage breast cancer: What is the appropriate duration?
John P Micha, Mark A Rettenmaier, Randy D Bohart, Bram H Goldstein

J Obstet Gynaecol Res· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II, open-label, non-randomized, prospective study assessing paclitaxel, carboplatin and metformin in the treatment of advanced stage ovarian carcinoma.
John P Micha, Mark A Rettenmaier, Randy D Bohart, Bram H Goldstein

J Gynecol Oncol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Talc powder and ovarian cancer: what is the evidence?
John P Micha, Mark A Rettenmaier, Randy Bohart, Bram H Goldstein

Arch Gynecol Obstet· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hormone Therapy and Risk of Breast Cancer: Where Are We Now?
John P Micha, Mark A Rettenmaier, Randy D Bohart, Bram H Goldstein

J Menopausal Med· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Robotic-Assisted Surgery for the Treatment of Breast and Cervical Cancers.
John P Micha, Mark A Rettenmaier, Randy D Bohart, Bram H Goldstein

JSLS· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncolytic viral therapy engenders a clinical response in a recurrent ovarian cancer patient.
John Micha, Mark Rettenmaier, Peter Giuliano, Randy Bohart, Bram Goldstein

Anticancer Drugs· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Rare Case of Idiopathic Pyometra in a Premenopausal Patient.
Kristina M Mori, Howard D Epstein, Michael C Roossin, Bram H Goldstein

J Menopausal Med· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Confounding variables in survival analysis: A response to the letter to the editor.
Mark A Rettenmaier, Bram H Goldstein

Eur J Obstet Gynecol Reprod Biol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A retrospective study comparing the efficacy of dose-dense chemotherapy, intraperitoneal chemotherapy and dose-dense chemotherapy with hyperthermic intraperitoneal chemotherapy in the treatment of advanced stage ovarian carcinoma.
Mark A Rettenmaier, John P Micha, Randy Bohart, Bram H Goldstein

Eur J Obstet Gynecol Reprod Biol· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pronounced clinical response following the oncolytic vaccinia virus GL-ONC1 and chemotherapy in a heavily pretreated ovarian cancer patient.
Kristina M Mori, Peter D Giuliano, Katrina L Lopez, Monica M King, Randy Bohart, Bram H Goldstein

Anticancer Drugs· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cranial and intra-axial metastasis originating from a primary ovarian Dysgerminoma.
Tiffany L Beck, Hitomi Momose, Jeffrey M Dym, Vikas Y Rao, Randy Bohart, Bram H Goldstein

Gynecol Oncol Rep· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Running Out of Time: Facilitating Off Label Approval in Cancer Treatment.
Alberto A Mendivil, Julie A Chad, Bram H Goldstein

J Clin Pharmacol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Management of a patient with a fragmented intrauterine device embedded within the cervical canal.
Patricia E Korber, Bram H Goldstein

Contraception· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dramatic clinical response following dabrafenib and trametinib therapy in a heavily pretreated low grade serous ovarian carcinoma patient with a BRAF V600E mutation.
Alberto A Mendivil, Paul K Tung, Randy Bohart, Karen Bechtol, Bram H Goldstein

Gynecol Oncol Rep· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clear cell carcinoma of the pelvic side wall arising from endometriosis.
Lisa N Abaid, John S Cupp, Miles Chang, Steven R Beanes, Bram H Goldstein

Gynecol Oncol Rep· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis